Get the Stockscreener App
66.91
1.38%
0.9144
Doximity Inc stock is traded at $66.91, with a volume of 536.98K.
It is up +1.38% in the last 24 hours and down -8.67% over the past month.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
See More
Previous Close:
$66.00
Open:
$66.44
24h Volume:
536.98K
Relative Volume:
0.38
Market Cap:
$9.13B
Revenue:
$550.17M
Net Income/Loss:
$201.35M
P/E Ratio:
66.91
EPS:
1
Net Cash Flow:
$232.07M
1W Performance:
-2.32%
1M Performance:
-8.67%
6M Performance:
+12.77%
1Y Performance:
+57.99%
1-Day Range:
$65.22
$66.93
1-Week Range:
$65.22
$69.00
52-Week Range:
$41.34
$85.21
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
66.92 | 12.36B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
291.87 | 47.73B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
89.58 | 15.61B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
94.52 | 8.15B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.06 | 6.86B | 906.14M | -52.62M | 89.62M | -0.3621 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-27-25 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-10-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-25 | Downgrade | Goldman | Neutral → Sell |
| Jul-09-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jun-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-07-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-07-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Nov-14-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-13-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-08-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Nov-08-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-09-24 | Upgrade | Needham | Hold → Buy |
| Jul-18-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Apr-25-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-09-23 | Downgrade | Needham | Buy → Hold |
| Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-31-22 | Initiated | Wells Fargo | Overweight |
| Oct-24-22 | Initiated | Evercore ISI | In-line |
| Oct-13-22 | Initiated | BTIG Research | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-28-22 | Initiated | Berenberg | Buy |
| May-18-22 | Reiterated | BofA Securities | Neutral |
| May-18-22 | Reiterated | Goldman | Buy |
| May-18-22 | Reiterated | Guggenheim | Buy |
| May-18-22 | Reiterated | Jefferies | Buy |
| May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
| May-18-22 | Reiterated | Needham | Buy |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-04-22 | Initiated | BofA Securities | Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-17-21 | Initiated | Robert W. Baird | Outperform |
| Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-21 | Reiterated | Goldman | Neutral |
| Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Nov-10-21 | Reiterated | Needham | Buy |
| Nov-10-21 | Reiterated | Piper Sandler | Overweight |
| Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-19-21 | Initiated | Canaccord Genuity | Buy |
| Jul-19-21 | Initiated | Goldman | Neutral |
| Jul-19-21 | Initiated | JP Morgan | Overweight |
| Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-21 | Initiated | Piper Sandler | Overweight |
| Jul-19-21 | Initiated | Raymond James | Outperform |
| Jul-19-21 | Initiated | SVB Leerink | Outperform |
| Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
Is Doximity Inc. stock attractive for hedge funds2025 Stock Rankings & Expert Curated Trade Ideas - newser.com
Will Doximity Inc. Class stock split increase liquidityBuy Signal & Free Daily Entry Point Trade Alerts - newser.com
Harel Insurance Investments & Financial Services Ltd. Makes New Investment in Doximity, Inc. $DOCS - MarketBeat
Is Doximity Inc. stock overvalued by current metricsQuarterly Market Review & Verified Technical Trade Signals - newser.com
Will Doximity Inc. stock recover faster than marketShare Buyback & Consistent Income Trade Recommendations - newser.com
Is Doximity Inc. stock a buy on dipsRisk Management & Weekly Chart Analysis and Trade Guides - newser.com
How risky is Doximity Inc. Class stock compared to peersJuly 2025 Outlook & Growth Focused Entry Reports - newser.com
Why Doximity Inc. stock is a value investor pickBond Market & Real-Time Stock Movement Alerts - newser.com
Real time social sentiment graph for Doximity Inc.2025 Momentum Check & Safe Capital Preservation Plans - newser.com
Can Doximity Inc. Class stock deliver strong annual returnsQuarterly Portfolio Summary & AI Enhanced Execution Alerts - newser.com
Will a bounce in Doximity Inc. offer an exitDip Buying & High Accuracy Swing Entry Alerts - newser.com
Does Doximity Inc. qualify in momentum factor screeningJuly 2025 Big Picture & Smart Allocation Stock Tips - newser.com
Tick level data insight on Doximity Inc. volatilityJuly 2025 Fed Impact & Expert Approved Momentum Trade Ideas - newser.com
Live market analysis of Doximity Inc.Earnings Summary Report & Safe Capital Growth Stock Tips - newser.com
How to forecast Doximity Inc. trends using time seriesJuly 2025 Summary & Reliable Volume Spike Alerts - newser.com
Will Doximity Inc. stock recover faster than peersWeekly Loss Report & Reliable Trade Execution Plans - newser.com
Retirement Systems of Alabama Trims Stock Position in Doximity, Inc. $DOCS - MarketBeat
Backtesting results for Doximity Inc. trading strategiesNew Guidance & Free Accurate Trade Setup Notifications - newser.com
What Catalysts Could Shift the Narrative for Doximity Amid Analyst Debate? - Yahoo Finance
Is There Now An Opportunity In Doximity, Inc. (NYSE:DOCS)? - 富途牛牛
Why hedge funds are buying Doximity Inc. stock2025 Top Gainers & Technical Confirmation Trade Alerts - newser.com
Will earnings trigger a reversal in Doximity Inc.2025 Technical Patterns & Reliable Price Action Trade Plans - newser.com
Doximity downgraded at J.P. Morgan on valuation and advertising concerns - MSN
Doximity, Inc. (DOCS) Analyst insights, Price targets and Recommendations - Yahoo! Finance Australia
Doximity (DOCS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.12%
3.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):